Matches in Wikidata for { <http://www.wikidata.org/entity/Q66409352> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q66409352 description "clinical trial" @default.
- Q66409352 description "ensayu clínicu" @default.
- Q66409352 description "klinisch onderzoek" @default.
- Q66409352 description "клінічне випробування" @default.
- Q66409352 name "Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis" @default.
- Q66409352 name "Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis" @default.
- Q66409352 type Item @default.
- Q66409352 label "Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis" @default.
- Q66409352 label "Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis" @default.
- Q66409352 prefLabel "Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis" @default.
- Q66409352 prefLabel "Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis" @default.
- Q66409352 P1050 Q66409352-9556D658-9C62-4865-B4B3-6EB81EB8CB5F @default.
- Q66409352 P1132 Q66409352-B2FF4956-9FE2-420B-A814-7F03D337F49C @default.
- Q66409352 P1476 Q66409352-0C0661BD-398B-46E7-A97D-A4ACA2AE0046 @default.
- Q66409352 P17 Q66409352-0D4F4C9C-E87E-467F-8AD3-62B3B7B0CDB5 @default.
- Q66409352 P17 Q66409352-2ACFBB5F-477F-4ED9-88F0-7BBA494F36BE @default.
- Q66409352 P17 Q66409352-3530EA3A-6BB4-4190-AD5B-285E232C7B54 @default.
- Q66409352 P17 Q66409352-386E4D93-2E24-45F7-BA3B-C99FBE099C42 @default.
- Q66409352 P17 Q66409352-41ECA8DD-E6AB-425D-B250-7ADFC6B12A3F @default.
- Q66409352 P17 Q66409352-4B31841F-E484-45AB-843D-5F19EAE87447 @default.
- Q66409352 P17 Q66409352-75F5957E-5EFF-4FF0-B6DC-310AE916A7AA @default.
- Q66409352 P17 Q66409352-84811BA3-AC56-4BEC-BFE9-44B44BDC2BBE @default.
- Q66409352 P17 Q66409352-9BA00BDA-E4CF-4E08-9CA6-93A084BD6FC2 @default.
- Q66409352 P17 Q66409352-B1148465-78F2-41F7-BD65-281B2F1A9299 @default.
- Q66409352 P17 Q66409352-DA833998-95A3-45DF-A1D1-B4C2F5FAB828 @default.
- Q66409352 P17 Q66409352-FDAF6201-5137-4C1F-9E18-96F0357F595F @default.
- Q66409352 P2899 Q66409352-C41DD980-5763-4869-B4E3-85B828EC100F @default.
- Q66409352 P3098 Q66409352-BE6B923A-438F-4F63-872A-209B6465E313 @default.
- Q66409352 P31 Q66409352-82909957-9AC1-4091-B9E8-2654C4AF088C @default.
- Q66409352 P4135 Q66409352-2589811B-DFA4-4679-9EFF-AED86242AB4F @default.
- Q66409352 P580 Q66409352-3C3AEB92-E6CA-4504-B581-4159DD85C19D @default.
- Q66409352 P582 Q66409352-8F7345A4-3E9E-4E57-978D-16A6904FAD85 @default.
- Q66409352 P6099 Q66409352-80421ED3-7274-47FF-A7FC-BD20FD33A545 @default.
- Q66409352 P8363 Q66409352-67785BAD-EF4E-47AA-9080-83C5C097AEF4 @default.
- Q66409352 P1050 Q170990 @default.
- Q66409352 P1132 "+430" @default.
- Q66409352 P1476 "Long-term Assessment of Safety, Efficacy, Pharmacokinetics and Immunogenicity of BI 695501 in Patients With Rheumatoid Arthritis (RA): an Open-label Extension Trial for Patients Who Have Completed Trial 1297.2 and Are Eligible for Long-term Treatment With Adalimumab" @default.
- Q66409352 P17 Q183 @default.
- Q66409352 P17 Q191 @default.
- Q66409352 P17 Q212 @default.
- Q66409352 P17 Q219 @default.
- Q66409352 P17 Q28 @default.
- Q66409352 P17 Q29 @default.
- Q66409352 P17 Q298 @default.
- Q66409352 P17 Q30 @default.
- Q66409352 P17 Q36 @default.
- Q66409352 P17 Q403 @default.
- Q66409352 P17 Q833 @default.
- Q66409352 P17 Q869 @default.
- Q66409352 P2899 "+18" @default.
- Q66409352 P3098 "NCT02640612" @default.
- Q66409352 P31 Q30612 @default.
- Q66409352 P4135 "+80" @default.
- Q66409352 P580 "2016-01-22T00:00:00Z" @default.
- Q66409352 P582 "2017-11-01T00:00:00Z" @default.
- Q66409352 P6099 Q42824827 @default.
- Q66409352 P8363 Q78089383 @default.